8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2017 / Controlled clinical trial
A controlled study tested whether consuming or avoiding food at night affected glucose metabolism in 11 healthy men during four simulated night shifts. Eating at night resulted in significant increases in glucose area under the curve post breakfast on shift day 4 (p = 0.05) and upon return to day shift (p < 0.001). Conversely, the group that abstained from nighttime eating did not experience significant increases in glucose area under the curve.
Grant CL, Coates AM, Dorrian J, et al. Chronobiol Int, 2017. PMID 28635334
2017 / Clinical trial (before-and-after)
Fifteen healthy adults completed an oral glucose tolerance test before and after one day of consuming a diet providing 78% excess energy with 68% of calories from fat. Postprandial glucose area under the curve rose by 17.1% (p < 0.0001) and insulin area under the curve rose by 16.4% (p = 0.007). Whole-body insulin sensitivity measured by the Matsuda index decreased by 28% (p = 0.001).
Parry SA, Woods RM, Hodson L, et al. Nutrients, 2017. PMID 28758920
2017 / Randomized crossover trial
In a randomized crossover trial, 18 healthy individuals and 18 individuals with type 2 diabetes completed a test day with breakfast and lunch and a test day with lunch only. Omission of breakfast altered postprandial clock and metabolic gene expression in both groups, showing distinct expression changes in genes such as Per1, Cry1, Rora, Sirt1, and Bmal1. Authors concluded that breakfast acutely affects clock gene expression leading to normal oscillation, while breakfast skipping adversely affects clock gene expression and is correlated with increased postprandial glycemic response.
Jakubowicz D, Wainstein J, Landau Z, et al. Diabetes Care, 2017. PMID 28830875
2017 / Randomized controlled trial
Adults with metabolic syndrome were randomized to consume either freeze-dried blueberry smoothies or a placebo twice daily for six weeks. Blueberry supplementation reduced superoxide and total reactive oxygen species in monocytes and whole blood compared to placebo (p ≤ 0.05). It also raised myeloid dendritic cell counts, decreased monocyte expression of TNF-alpha, IL-6, and TLR4, and decreased circulating GMCSF levels (p ≤ 0.05).
Nair AR, Mariappan N, Stull AJ, et al. Food Funct, 2017. PMID 29019365
2017 / Randomized crossover trial
Forty healthy older adults aged 50 to 70 consumed a mixed berry beverage or a matched control beverage daily for five weeks in a randomized crossover trial. The berry drink reduced total and LDL cholesterol compared to baseline (P < 0.05) and compared to control (P < 0.005 and P < 0.01). Working memory performance improved after the berry beverage compared to control (P < 0.05), but other cardiometabolic variables remained unchanged.
Nilsson A, Salo I, Plaza M, et al. PLoS One, 2017. PMID 29141041
2017 / Prospective randomized placebo-controlled study
Thirty-two therapy-naïve type 2 diabetes patients were randomized to receive either 8 grams per day of Moringa oleifera (MO) leaf capsules or placebo for 4 weeks. There was no significant difference in FPG and HbA1C between groups, and no adverse effects were observed. The MO leaf group experienced a 5 mmHg reduction in systolic blood pressure compared to baseline, but this change was not statistically significant.
Taweerutchana R, Lumlerdkij N, Vannasaeng S, et al. Evid Based Complement Alternat Med, 2017. PMID 29317895
2016 / Randomized controlled trial
In a randomized, double-blind, placebo-controlled pilot study, 25 women with polycystic ovary syndrome consumed marjoram tea (n=14) or placebo tea (n=11) twice daily for one month. Marjoram intake significantly lowered DHEA-S by a mean of 1.4 μmol/L and fasting insulin by 1.9 μU/mL within the group. Relative to placebo, reductions were statistically significant for DHEA-S (P=0.05) and HOMA-IR (P<0.05), while fasting insulin changes did not differ significantly (P=0.08).
Haj-Husein I, Tukan S, Alkazaleh F J Hum Nutr Diet, 2016. PMID 25662759
2016 / Randomized controlled trial
In a randomized, double-blind trial, 80 obese women received 2 g daily of ginger powder or placebo for 12 weeks. Ginger supplementation significantly decreased body mass index, serum insulin, and HOMA-IR index, while increasing QUICKI values compared to placebo. Decreases in leptin, resistin, and glucose occurred in both cohorts without significant differences between groups, whereas body composition and adiponectin concentrations remained unchanged.
Ebrahimzadeh Attari V, Ostadrahimi A, Asghari Jafarabadi M, et al. Eur J Nutr, 2016. PMID 26318445
2016 / Randomized crossover trial
In a randomized crossover trial, 11 healthy volunteers ingested 300 mL of light roast coffee, dark roast coffee, or water prior to an oral glucose tolerance test. Neither coffee altered overall glucose area under the curve compared with water, though dark roast produced higher glucose at 60 minutes. Both roasts significantly raised insulin concentrations and lowered insulin sensitivity indices relative to water, without differing from each other.
Rakvaag E, Dragsted LO Eur J Nutr, 2016. PMID 26342706
2016 / Double-blind, randomized, crossover trial
In a randomized, double-blind crossover trial, 14 patients with diet-controlled type 2 diabetes received resveratrol (500 mg twice daily) or placebo for two 5-week periods separated by a 5-week washout. Fasting and postprandial blood glucose, plasma total GLP-1, and gastric emptying were similar at each assessment, and changes from weeks 0 to 5 did not differ between resveratrol and placebo. Changes in HbA1c, daily energy intake, and body weight after 5 weeks also showed no significant differences between treatments.
Thazhath SS, Wu T, Bound MJ, et al. Am J Clin Nutr, 2016. PMID 26607942
2016 / Randomized controlled trial
In the Bath Breakfast Project, 23 obese adults were randomly assigned to daily breakfast (≥700 kcal before 1100) or extended fasting (0 kcal until 1200) for 6 weeks under free-living conditions. Breakfast resulted in greater physical activity thermogenesis during the morning (difference: 188 kcal/d; 95% CI: 40, 335), but without a consistent effect over 24 hours. Energy intake was not significantly greater with breakfast (difference: 338 kcal/d; 95% CI: -313, 988). Body mass increased across both groups over time with no treatment effects on body composition or resting metabolic rate, while daily breakfast was associated with a reduced insulinemic response to an oral-glucose-tolerance test relative to an increase with fasting (P = 0.05).
Chowdhury EA, Richardson JD, Holman GD, et al. Am J Clin Nutr, 2016. PMID 26864365
2016 / Randomized crossover trial
A randomized crossover pilot trial evaluated 26 adults with type 2 diabetes who consumed 1,200 mg of aged garlic extract or placebo daily for 4 weeks. Supplementation had no significant effect on insulin resistance or metabolic measures. In addition, aged garlic extract did not significantly alter markers of endothelial function, oxidative stress, or vascular inflammation in this high-risk population.
Atkin M, Laight D, Cummings MH J Diabetes Complications, 2016. PMID 26954484
2016 / Randomized controlled trial
In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.
Yari Z, Rahimlou M, Eslamparast T, et al. Int J Food Sci Nutr, 2016. PMID 26983396
2016 / Randomized crossover trial
In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.
Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559
2016 / Clinical trial
Thirty adults with type 2 diabetes followed an eight-week very low-calorie diet before returning to an isocaloric maintenance plan. Body weight dropped from 98.0 ± 2.6 to 83.8 ± 2.4 kg and remained stable at 84.7 ± 2.5 kg at six months. Fasting blood glucose normalized below 7 mmol/L in 12 participants after refeeding and in 13 participants at six months, accompanied by recovered first-phase insulin response.
Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Diabetes Care, 2016. PMID 27002059
2016 / Randomized placebo-controlled trial
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610
2016 / Double-blind, placebo-controlled, balanced crossover trial
In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).
Wong RH, Nealon RS, Scholey A, et al. Nutr Metab Cardiovasc Dis, 2016. PMID 27105868
2016 / Randomized, double-blind, placebo-controlled clinical trial
A randomized, double-blind, placebo-controlled pilot trial assigned 44 patients with NAFLD to receive either 2 grams per day of a ginger supplement or an identical placebo for 12 weeks, with both groups advised to follow a modified diet and physical activity program. Compared to placebo, ginger supplementation led to significant reductions in alanine aminotransferase, γ-glutamyl transferase, inflammatory cytokines, insulin resistance index, and hepatic steatosis grade. No significant effect was found on hepatic fibrosis or aspartate aminotransferase.
Rahimlou M, Yari Z, Hekmatdoost A, et al. Hepat Mon, 2016. PMID 27110262
2016 / Randomized controlled trial
A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.
Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322
2016 / Randomized controlled trial
Nineteen healthy adults completed a 4-day inpatient protocol under dim light conditions and were randomized to 3 hours of blue-enriched light exposure either 0.5 hours after waking (n=9) or 10.5 hours after waking (n=10) on Day 3, with Day 2 serving as baseline. In both groups, insulin total area, HOMA-IR, and HOMA-IR AUC were increased, and subjective sleepiness was reduced with blue-enriched light compared to dim light. The evening group, but not the morning group, exhibited a significantly higher peak glucose value during blue-enriched light exposure compared to dim light. There were no other significant differences between morning and evening groups in response to blue-enriched light.
Cheung IN, Zee PC, Shalman D, et al. PLoS One, 2016. PMID 27191727
2016 / Retrospective analysis of a dietary intervention study
Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.
Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019
2016 / Randomized controlled trial
In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.
Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187
2016 / Randomized controlled trial
Participants with type 2 diabetes were randomly assigned to follow either a vegan diet (n = 46) or a conventional diet recommended by the Korean Diabetes Association 2011 (n = 47) for 12 weeks. Both groups experienced significant reductions in HbA1c, but reductions were larger in the vegan group than in the conventional group (-0.5% vs. -0.2%; p-for-interaction = 0.017). Among participants with high compliance, the reduction difference between groups was larger (-0.9% vs. -0.3%), remaining significant after adjusting for changes in total energy intake or waist circumference. The authors noted that further studies are needed to evaluate the long-term effects of a vegan diet.
Lee YM, Kim SA, Lee IK, et al. PLoS One, 2016. PMID 27253526
2016 / Randomized controlled trial and animal study
A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.
Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343